pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Reagent Pharma Companies Scientist 52

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

XTalks

OCTOBER 1, 2020

Moreover, Dr. Lin explains that in an academic lab, you are supposed to do everything – from ordering reagents, to washing dishes to doing an in vitro study for a project and then the in vivo work, through to completion. But in companies, you cannot do that. Funding in the Life Science Industry vs. Academia.

Scientist 52

Scientist In-Vitro Research Life Science 52

XTalks

DECEMBER 5, 2024

Related: Top 10 Most Environmentally Sustainable Pharma Companies in 2023/2024 BioMADE focuses on advancing US industrial biomanufacturing innovations and fostering workforce development to strengthen the country’s competitiveness in biotechnology.

Reagent 111

Reagent Production Cosmetics Pharma Companies 111

XTalks

JANUARY 6, 2025

Biomanufacturing and Automation The production of vaccines, drugs and diagnostic reagents increasingly depends on good manufacturing practice (GMP) facilities for the manufacturing of critical reagents, a reliance that has intensified since the pandemic. percent from 2021 to 2031, reaching an estimated value of $85.2 billion by 2031.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111

XTalks

MARCH 11, 2025

Rapid assays that can deliver same-day results are highly attractive to pharma companies, as they eliminate lengthy sample queues often seen with centralized or outsourced testing. The result was a prepackaged, off-the-shelf reagent kit that provided reliable quantification for a wide variety of influenza mRNA vaccine constructs.

Vaccination 64

Vaccination Vaccine Development Manufacturing 64